ABL Bio Technologies Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30 2016 under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.